Search Results - "JAAD Case Reports"
-
1
Coronavirus (COVID-19) infection–induced chilblains: A case report with histopathologic findings
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.06.2020Published in JAAD Case Reports (01.06.2020)Get full text
Journal Article -
2
Varicella-zoster virus reactivation after SARS-CoV-2 BNT162b2 mRNA vaccination: Report of 5 cases
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.06.2021Published in JAAD Case Reports (01.06.2021)Get full text
Journal Article -
3
Oral angiotensin-converting enzyme inhibitors for treatment of delayed inflammatory reaction to dermal hyaluronic acid fillers following COVID-19 vaccination-a model for inhibition of angiotensin II–induced cutaneous inflammation
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.04.2021Published in JAAD Case Reports (01.04.2021)Get full text
Journal Article -
4
Introduction to reflectance confocal microscopy and its use in clinical practice
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.11.2018Published in JAAD Case Reports (01.11.2018)“…Reflectance confocal microscopy (RCM) is a novel technology that provides noninvasive, in vivo imaging of the skin at nearly histologic resolution. In 2016,…”
Get full text
Journal Article -
5
“COVID arm”: A reaction to the Moderna vaccine
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.04.2021Published in JAAD Case Reports (01.04.2021)Get full text
Journal Article -
6
Morbilliform exanthem associated with COVID-19
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.06.2020Published in JAAD Case Reports (01.06.2020)Get full text
Journal Article -
7
Urticarial exanthem as early diagnostic clue for COVID-19 infection
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.06.2020Published in JAAD Case Reports (01.06.2020)Get full text
Journal Article -
8
Bullous pemphigoid treated with Janus kinase inhibitor upadacitinib
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.02.2023Published in JAAD Case Reports (01.02.2023)Get full text
Journal Article -
9
Severe cutaneous ulcerations secondary to xylazine (tranq): A case series
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.06.2023Published in JAAD Case Reports (01.06.2023)Get full text
Journal Article -
10
Spesolimab use in treatment of pyoderma gangrenosum
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.04.2023Published in JAAD Case Reports (01.04.2023)Get full text
Journal Article -
11
Acute generalized pustular psoriasis exacerbated by the COVID-19 vaccine
ISSN: 2352-5126, 2352-5126Published: Elsevier Inc 01.11.2021Published in JAAD Case Reports (01.11.2021)Get full text
Journal Article -
12
A case of severe cutaneous adverse reaction following administration of the Janssen Ad26.COV2.S COVID-19 vaccine
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.07.2021Published in JAAD Case Reports (01.07.2021)Get full text
Journal Article -
13
Drug-induced alopecia after dupilumab therapy
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.01.2019Published in JAAD Case Reports (01.01.2019)Get full text
Journal Article -
14
Refractory dermatomyositis responsive to anifrolumab
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.01.2024Published in JAAD Case Reports (01.01.2024)Get full text
Journal Article -
15
Xylazine-induced acute skin necrosis in two patients who inject fentanyl
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.06.2023Published in JAAD Case Reports (01.06.2023)Get full text
Journal Article -
16
Vitiligo during dupilumab therapy
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.06.2023Published in JAAD Case Reports (01.06.2023)Get full text
Journal Article -
17
Dupilumab-induced phenotype switching from atopic dermatitis to psoriasis
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.03.2020Published in JAAD Case Reports (01.03.2020)Get full text
Journal Article -
18
Two cases of bullous pemphigoid effectively treated with oral tofacitinib
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.02.2023Published in JAAD Case Reports (01.02.2023)Get full text
Journal Article -
19
Dupilumab for the treatment of severe atopic dermatitis in a pregnant patient: A case report
ISSN: 2352-5126, 2352-5126Published: Elsevier Inc 01.10.2020Published in JAAD Case Reports (01.10.2020)Get full text
Journal Article -
20
Tofacitinib shows benefit in conjunction with other therapies in recalcitrant hidradenitis suppurativa patients
ISSN: 2352-5126, 2352-5126Published: United States Elsevier Inc 01.02.2020Published in JAAD Case Reports (01.02.2020)Get full text
Journal Article